Entera Bio Ltd (ENTX)
2.425
-0.18
(-6.73%)
USD |
NASDAQ |
May 17, 16:00
2.49
+0.06
(+2.68%)
After-Hours: 20:00
Entera Bio Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
Date | Value |
---|---|
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
--
Maximum
Jun 2019
--
Average
--
Median
Jun 2019
Debt to Equity Ratio Benchmarks
BiomX Inc | -- |
Compugen Ltd | 0.00 |
Pluri Inc | -67.60 |
BioLine Rx Ltd | 0.7391 |
Can Fite Biofarma Ltd | 0.00 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 10.24M |
Total Liabilities (Quarterly) | 1.376M |
Shareholders Equity (Quarterly) | 8.863M |